D1/D2 receptor synergism on CREB DNA-binding activities in the caudate- putamen of rat

Neurological Research

Volumn 21, Issue 8, 1999, Pages 781-784

  Kashihara, Kenichi ^a   Ishihara, Takeshi ^a   Akiyama, Kazufumi ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CREB; Dopamine receptor; Striatum; Synergism

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; BROMOCRIPTINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; OXIDOPAMINE; PROTEIN C FOS; QUINPIROLE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CATECHOLAMINE DEPLETION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN INDUCTION; PUTAMEN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032701324     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11741014     Document Type: Article

References (24)

1. Gershanik O, Heikkila RE, Duvoisin RC. Behavioral correlations of dopamine receptor activation. Neurology 1983; 33: 1489-1492
2. Herrera-Marschitz M, Forster C, Ungerstedt U. Rotational behavior elicited by intracerebral injection of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat in heterogenously organized for rotational behavior. Acta Physiol Scand 1985; 125: 529-535
3. Robertson GS, Robertson HA. Synergistic effects of dopamine agonists on turning behavior in rats. Brain Res 1986; 384: 387-390
4. Carlson JH, Bergstrom DA, Weick BG, Walters JR. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study. Brain Res 1987; 400: 205-218
5. Schinelli S, Paolillo M, Corona GL. Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J Neurochem 1994; 62: 944-949
6. Paul ML, Graybiel AM, David J-C, Robertson HA. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci 1992; 12: 3729-3742
7. LaHoste C, Yu J, Marshall JF. Striatal fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 1993; 90: 7451-7455
8. Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T. Synergistic effect of D1 and D2 dopamine receptors on AP-1 DMA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medial forebrain bundle. Life Sci 1996; 59: 1683-1693
9. Duman RS, Heninger GR, Nestler EJ. Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 1994; 182: 692-700
10. Stoof JC, Kebabian JW. Opposing role for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 1981; 294: 366-368
11. Pellegrino LJ, Pellegrino AS, Cushman AJH. A Stereotaxic Atlas of the Rat Brain, New York: Plenum Press, 1979
12. Huang K-X, Walters JR. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. Neuroscience 1996; 75: 757-775
13. Cole DG, Kobierski LA, Konradi C, Hyman SE. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cyclic AMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci USA 1994; 91: 9631-9635
14. Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T. Levodopa but not bromocriptine induces AP-1 and CREB DNA-binding activity in the dopamine-depleted striatum of the rat. Life Sci 1996; 58: PL159-170
15. Yamamoto KK, Gonzalez GA, Biggs WH III, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988; 334: 494-498
16. Weiner DM, Levey AI, Sunahara RK, Niznik HB, O'Dowd BF, Seeman P, Brann MR. D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 1991; 88: 1859-1863
17. 7 Lester J, Fink S, Aronin N, DiFiglia M. Colocalizaiton of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res 1993; 621: 106-110
18. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres M-P, Schwartz J-C. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 1991; 353: 164-167
19. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979; 277: 93-96
20. Enjalbert A, Sladeczek F, Guillon G, Bertrund P, Shu C, Epelbaum J, Garcia-Sainz A, Jard J, Lombard C, Kordon C, Bockaert J. Angiotensin II and dopamine modulate both cyclic AMP and inositolphosphate production in anterior pituitary cell. J Biol Chem 1986; 261: 4071-4075
21. 2 dopamine receptor synergism. Nature 1990; 347: 386-388
22. Sheng M, Thompson MA, Greenberg ME. CREB: A Ca(2 + )-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991; 252: 1427-1430
23. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990; 250: 1429-1432
24. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990; 13: 244-254